Evidence of Effectiveness and the Selection of Treatment
2. Treatment for an Acute Exacerbation
Intravenous Methylprednisolone
Intravenous Dexamethasone
Intramuscular Adrenocorticotropic Hormone
Aspirin and Nonsteroidal Antiinflammatory Drugs
3. Treatments That Affect the Long-Term Course of the Disease ("Disease-Modifying Therapy")
From Better Understanding to Better Treatment
Drugs Approved for Use in MS
Treatments That Are Not Specifically Approved for MS But Are Being Used in Certain Parts of the World
Intravenous Immunoglobulin
Total Lymphoid Irradiation
Acyclovir and Other Antiviral Agents
Bone Marrow Transplantation and Hemopoietic Stem Cell Transplantation
Treatments Under Development
Monoclonal Antibodies to Lymphocytes
Agents That Interfere with Cytokine Production/Activity
Agents That Induce Specific Immunosuppression
Administration of MBP and Other Peptides
T Cell (Receptor) Vaccination
Agents That Reduce Blood-Brain Barrier Injury
4. Symptomatic Treatment and Rehabilitation
Symptomatic Treatment of MS
Other Paroxysmal Symptoms
Evaluating Neurorehabilitation in MS
Evaluating Comprehensive Packages of Rehabilitation
Do Benefits of Rehabilitation Carry Over in Medium Term?
Evaluating Components of the Rehabilitaion Package
Evaluating Service Delivery
5. Alternative Therapies Used by People with MS
Definition of Alternative or Complementary Medicine
Popularity of Alternative Medicine
Miscellaneous Empirical Treatments
Injected Materials and Oral Administration
Physical and Surgical Manipulations
